Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | ADCY3 |
| Upstream (Parents) |
|---|
| (<<) BZW1 → ADCY3 |
| (<<) CEBPB → ADCY3 |
| (<<) CHAF1A → ADCY3 |
| (<<) CSNK1A1 → ADCY3 |
| (<<) CTPS → ADCY3 |
| (<<) ELF4 → ADCY3 |
| (<<) HLA-A → ADCY3 |
| (<<) HLA-F → ADCY3 |
| (<<) MRAS → ADCY3 |
| (<<) NPC1 → ADCY3 |
| (<<) NRIP1 → ADCY3 |
| (<<) PRKCQ → ADCY3 |
| (<<) RAB5B → ADCY3 |
| (<<) RPIA → ADCY3 |
| (<<) RPS14 → ADCY3 |
| (<<) TCF7L1 → ADCY3 |
| (<<) TMEM39B → ADCY3 |
| (<<) TMEM87B → ADCY3 |
| Downstream (Children) |
|---|
| ADCY3 → ANKRD27 (>>) |
| ADCY3 → AREG (>>) |
| ADCY3 → ATXN1 (>>) |
| ADCY3 → CFL2 (>>) |
| ADCY3 → CHI3L1 (>>) |
| ADCY3 → COTL1 (>>) |
| ADCY3 → CXCL1 (>>) |
| ADCY3 → CYP27B1 (>>) |
| ADCY3 → ETS1 (>>) |
| ADCY3 → GNE (>>) |
| ADCY3 → HDAC9 (>>) |
| ADCY3 → ITGA3 (>>) |
| ADCY3 → MAP3K14 (>>) |
| ADCY3 → MAPK7 (>>) |
| ADCY3 → NAGS (>>) |
| ADCY3 → NFIL3 (>>) |
| ADCY3 → ROBO3 (>>) |
| ADCY3 → SAA4 (>>) |
| ADCY3 → TNFRSF11A (>>) |
| ADCY3 → TSC22D1 (>>) |
